anti-IL-3 mAbs (University of Regensburg)

N/A

Report date: 2025/03/14 16:49:00

Base Information

Drug Nameanti-IL-3 mAbs (University of Regensburg)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionInterleukin 3 receptor antagonists
TargetsInterleukin 3 receptor
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Regensburg
China Registration ClassN/A

Develop Information

Active CompaniesBayerische Patentallianz GmbHUniversity Of Regensburg
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A